Aardvark Therapeutics, Inc. · NASDAQ:AARD

Aardvark Therapeutics, Inc. shareholders

As of Sep 30, 2026, 74 institutions reported holding Aardvark Therapeutics, Inc., 43.6% of its shares. Largest: Decheng Capital LLC, Laurion Capital Management LP and Citadel. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Aardvark Therapeutics, Inc.ChangeFiled
Decheng Capital LLC3.92M17.9%no changeNov 13, 2026
Laurion Capital Management LP1.03M4.7%no changeOct 30, 2026
Citadel975K4.5%−308KNov 16, 2026
EcoR1 Capital, LLC720K3.3%+324KNov 16, 2026
Vanguard639K2.9%−4,951Nov 13, 2026
ExodusPoint Capital Management, LP316K1.4%newNov 16, 2026
BlackRock195K0.89%+7,575Nov 13, 2026
Geode Capital139K0.63%−10,837Nov 6, 2026
Marshall Wace, LLP132K0.60%+113KNov 13, 2026
Jacobs Levy Equity Management, Inc130K0.59%newNov 16, 2026

Aardvark Therapeutics, Inc. insider trades